Individual reevaluation therapy Primairy Cardiovascular Preventio
- Conditions
- therapy to prevent cardiovascular disease10082206
- Registration Number
- NL-OMON32052
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
patients of 18 years and older who have used medication to lower the blood pressure or to lower cholesterol in the past 12 months and who are not known to have cardiovascular disease
Exclusion Criteria
serious cognitive impairment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Endpoints<br /><br><br /><br>• Number and proportion of patients using medication for primary prevention of<br /><br>cardiovascular disease who are willing to participate in a reevaluation of the<br /><br>cardiovascular risk.<br /><br>• Number and proportion of patients who do not need preventive cardiovascular<br /><br>medication according to the new guidelines for cardiovascular risk management<br /><br>and who are willing to discontinue the medication.</p><br>
- Secondary Outcome Measures
Name Time Method <p>The savings in yearly costs of medication duet o discontinuation of medication<br /><br>(total costs in euros for this medication of all patients in 2007 vs 2010,<br /><br>extrapolated on the basis of 3% index).</p><br>